Skip to main content
VivoSim Labs, INC. logo

VivoSim Labs, INC. — Investor Relations & Filings

Ticker · VIVS ISIN · US68620A2033 US Professional, scientific and technical activities
Filings indexed 790 across all filing types
Latest filing 2026-04-02 Prospectus
Country US United States of America
Listing US VIVS

About VivoSim Labs, INC.

https://organovo.com/

VivoSim Labs, Inc. is a biotechnology services company that develops and utilizes bioprinted, three-dimensional (3D) human tissues designed to emulate human biology and disease. The company provides testing services for drugs and drug candidates, primarily for the pharmaceutical and biotechnology sectors. VivoSim Labs specializes in offering liver and intestinal toxicology insights through its proprietary New Approach Methodologies (NAMs), including its NAMkind™ 3D models. These non-animal testing platforms are used to generate human-relevant safety and toxicology data early in the drug discovery and development process, aiming to provide insights before animal studies or clinical trials.

Recent filings

Filing Released Lang Actions
424B4 - VivoSim Labs, INC. (0001497253) (Filer)
Prospectus
2026-04-02 English
S-1/A - VivoSim Labs, INC. (0001497253) (Filer)
Registration Form
2026-03-31 English
S-1 - VivoSim Labs, INC. (0001497253) (Filer)
Registration Form
2026-03-27 English
10-Q Filing
Interim / Quarterly Report Q3 2025
2026-02-11 English
4 Filing
Director's Dealing
2026-01-29 English
4 Filing
Director's Dealing
2026-01-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.